緑内障診療クローズアップ

出版社： メジカルビュー社
著者：
発行日： 2014-04-10
分野： 臨床医学：外科  >  眼科学
ISBN： 9784758310888
電子書籍版： 2014-04-10 （第1版第3刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

12,100 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

12,100 円(税込)

購入する

商品紹介

緑内障は失明につながる疾患でありながら潜在患者が多く，未治療患者の早期発見，早期治療が求められている。また，長期にわたる緑内障治療は管理が難しく，眼圧コントロールに苦慮する症例も少なくない。治療水準の維持と向上が重視されている分野である。本書では，緑内障診療の基本を十分にかみくだき，眼圧，視野，眼底，OCTなどの検査から，点眼治療，術式の選択と術後管理まで，開業医を中心とした眼科医の日常診療に即役立つようまとめた1冊である。

目次

  • 緑内障診療クローズアップ

    ―目次―

    I 緑内障診療の基本
    　緑内障の疫学
    　緑内障に関連する遺伝子
    　緑内障診察の進め方
    　房水循環の生理
    　眼圧検査
    　　　眼圧計の種類と眼圧測定の実際
    　　　手持ち眼圧計の種類と眼圧測定の実際
    　　　眼圧に影響する因子：体位変動・日内変動
    　視野検査
    　　　視野検査に影響する因子
    　　　視野検査の種類と特徴
    　　　　　Humphrey静的視野解釈の基本
    　　　　　Goldmann動的視野解釈の基本
    　　　　　Octopus静的視野解釈の基本
    　　　　　早期発見のための視野検査
    　　　視野検査でみる進行評価
    　前眼部検査
    　　　スリットランプでみること
    　　　隅角鏡でみること
    　　　UBMと前眼部OCT
    　眼底検査
    　　　視神経乳頭所見の取り方
    　　　鑑別を要する乳頭所見
    　画像診断
    　　　OCT
    　　　HRT
    　　　その他の画像診断

    II 点眼治療
    　　　点眼治療の原則
    　　　眼圧下降以外の薬
    　　　アドヒアランス
    　　　緑内障患者に使えない薬
    　　　妊婦，小児への点眼薬処方

    III 術式選択と術後管理
    　トラベクレクトミー
    　　　トラベクレクトミー　適応病態と術後管理
    　　　トラベクレクトミー　合併症対策
    　濾過胞再建術
    　トラベクロトミー
    　　　トラベクロトミー　適応病態と術後管理
    　　　トラベクロトミー　合併症対策
    　その他の隅角手術
    　緑内障シャント手術
    　　　EX-PRESSTM手術　適応病態と術後管理，合併症対策
    　　　Baerveldtインプラント手術　適応病態と術後管理
    　　　Baerveldtインプラント手術　合併症対策
    　周辺虹彩切除術
    　　　周辺虹彩切除術　適応病態と術後管理，合併症対策
    　レーザー手術
    　　　虹彩のレーザー治療
    　　　隅角のレーザー治療
    　　　毛様体のレーザー治療

    IV 病型別診断と治療
    　原発開放隅角緑内障（広義）
    　　　原発開放隅角緑内障（狭義）
    　　　　　原発開放隅角緑内障（狭義）　診断?
    　　　　　原発開放隅角緑内障（狭義）　治療
    　　　　　正常眼圧緑内障　概論
    　　　　　正常眼圧緑内障　循環障害と緑内障
    　　　　　正常眼圧緑内障　緑内障と近視性視神経症
    　　　　　正常眼圧緑内障　緑内障の生活指導
    　　　　　正常眼圧緑内障　運転免許と緑内障
    　　　高眼圧症
    　　　　　高眼圧症　診断と治療
    　原発閉塞隅角緑内障
    　　　瞳孔ブロックによる閉塞隅角緑内障
    　　　　　瞳孔ブロックによる閉塞隅角緑内障　疫学と診断
    　　　　　瞳孔ブロックによる閉塞隅角緑内障　治療
    　　　プラトー虹彩緑内障
    　　　　　プラトー虹彩緑内障　診断と治療
    　　　急性原発閉塞隅角症
    　　　　　急性原発閉塞隅角症　診断
    　　　　　急性原発閉塞隅角症　治療
    　続発緑内障
    　　　ぶどう膜炎に続発する緑内障
    　　　水晶体疾患に関係する緑内障
    　　　　　水晶体脱臼
    　　　　　落屑緑内障
    　　　角膜疾患に続発する緑内障
    　　　ステロイド緑内障
    　　　網膜疾患に続発する緑内障
    　　　悪性緑内障
    　　　外傷性緑内障
    　発達緑内障
    　　　早発型発達緑内障　診断と治療
    　　　続発発達緑内障　診断と治療

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

(I) 緑内障診療の基本

P.5 掲載の参考文献
1) Iwase A, et al.:The prevalence of open-angle glaucoma in Japanese:the Tajimi Study. Ophthalmology, 111:1641-1648, 2004.
PubMed
2) Sawaguchi S, et al.:Prevalence of primary angle closure and primary angle-closure glaucoma in a southwestern rural population of Japan. Ophthalmology, 119:1134-1142, 2012.
 
3) Klein BE, et al.:Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology, 99:1499-1504, 1992.
PubMed
4) Leske MC, et al.:The Barbados Eye Study:Prevalence of Open Angle Glaucoma. Arch Ophthalmol, 112:821-829, 1994.
PubMed
5) Mitchell P, et al.:Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology, 103:1661-1669, 1996.
PubMed
6) Dielemans I, et al.:The prevalence of primary open-angle glaucoma in a population-based study in the Netherlands. The Rotterdam Study. Ophthalmology, 101:1851-1855, 1994.
 
7) Garudadri C, et al.:Prevalence and risk factors for primary glaucomas in adult urban and rural populations in the Andhra Pradesh Eye Disease Study. Ophthalmology, 117:1352-1359, 2010.
 
8) Varma R, et al.:Prevalence of open-angle glaucoma and ocular hypertension in Latinos:the Los Angeles Latino Eye Study. Ophthalmology, 111:1439-1448, 2004.
PubMed
9) Vijaya L, et al.:Prevalence of primary angle-closure disease in an urban south Indian population and comparison with a rural population. The Chennai Glaucoma Study. Ophthalmology, 115:165-160, 2008.
 
10) Wang Y, et al.:Prevalence of glaucoma in North China:the Beijing Eye Study, Am J Ophthalmol 150:917-924, 2010.
PubMed
P.13 掲載の参考文献
1) 日本緑内障学会:緑内障診療ガイドライン, 日本緑内障学会, 2003.
 
P.15 掲載の参考文献
1) Pepose JS, Ubels JL:The cornea. Adler's Physiology of the Eye, 9th ed, 29, CV Mosby, 1992.
 
2) Caprioli J:The ciliary epithelia and aqueous humor. Adler's Physiology of the Eye, 9th ed, 228, CV Mosby, 1992.
 
P.18 掲載の参考文献
1) Pekmezci M, et al.:Effect of measurement order between right and left eyes on intraocular pressure measurement. Arch Ophthalmol, 129:276-281, 2011.
PubMed
2) Gandhi PD, et al.:Attempted eyelid closure affects intraocular pressure measurement. Am J Ophthalmol, 131:417-420, 2001.
PubMed
3) Jamal KN, et al.:Attempted eyelid closure affects intraocular pressure measurement in open-angle glaucoma patients. Am J Ophthalmol, 134:186-189, 2002.
PubMed
4) Siganos DS, et al.:Assessment of the Pascal dynamic contour tonometer in monitoring intraocular pressure in unoperated eyes and eyes after LASIK. J Cataract Refract Surg, 30:746-751, 2004.
 
5) Ito K, et al.:IOP measured by dynamic contour tonometry correlates with IOP measured by Goldmann applanation tonometry and non-contact tonometry in Japanese individuals. J Glaucoma, 21:35-40, 2012.
PubMed
6) Tonuu PA, et al.:The influence of central corneal thickness and age on intraocular pressure measured by pneumotonometry, noncontact tonometry, the Tono-Pen XL, and Goldmann applanation tonometry. Br J Ophthalmol, 89:851-854, 2005.
PubMed
P.21 掲載の参考文献
1) Nakakura S, et al.:Intraocuar pressure of supine patients using four portable tonometers. Optom Vis Sci, 90:700-706, 2013.
 
2) Nakakura S, et al.:Intradevice and Interdevice Agreement Between a Rebound Tonometer, Icare PRO, and the Tonopen XL and Kowa Hand-held Applanation Tonometer When Used in the Sitting and Supine Position. J Glaucoma, 2013(in press).
 
3) Takenaka J, et al.:Intraocular pressure measurement using rebound tonometer for deviated angles and positions in human eyes. Curr Eye Res, 37:109-114, 2012.
PubMed
4) Nakamura M, et al.:Agreement of rebound tonometer in measuring intraocular pressure with three types of applanation tonometers. Am J Ophthalmol, 142:332-334, 2006.
PubMed
P.23 掲載の参考文献
1) Nakakura S, et al.:Intradevice and Interdevice Agreement Between a Rebound Tonometer, Icare PRO, and the Tonopen XL and Kowa Hand-held Applanation Tonometer When Used in the Sitting and Supine Position. J Glaucoma, 2013(in press).
 
2) Buys YM, et al.:Effect of sleeping in a head-up position on intraocular pressure in patients with glaucoma. Ophthalmology, 117:1348-1351, 2010.
 
3) Malihi M, et al.:Effect of head and body position on intraocular pressure. Ophthalmology, 119:987-991, 2012.
PubMed
4) De Koninck J, et al.:Sleep positions and position shifts in five age groups:an ontogenetic picture. Sleep, 15:143-149, 1992.
PubMed
5) Lee JY, et al.:The effect of lateral decubitus position on intraocular pressure in healthy young subjects. Acta Ophthalmol, 90:e68-72, 2012.
PubMed
6) Kim KN, et al.:Effect of lateral decubitus position on intraocular pressure in glaucoma patients with asymmetric visual field loss. Ophthalmology, 120:731-735, 2013.
PubMed
7) Qureshi IA, et al.:Effect of seasons upon intraocular pressure in healthy population of China. Korean J Ophthalmol, 10:29-33, 1996.
PubMed
8) Morgan WH, et al.:Wearing swimming goggles can elevate intraocular pressure. Br J Ophthalmol, 92:1218-1221, 2008.
PubMed
P.27 掲載の参考文献
1) 中野 匡:Goldmann 視野解釈の基本. 眼科プラクティス, 15, 90-95, 文光堂, 2007.
 
P.63 掲載の参考文献
1) Pavlin CJ, Het al.:Clinical use of ultrasound biomicroscopy. Ophthalmology, 98:287-295, 1991.
 
2) Kunimatsu S, et al.:Prevalence of appositional angle closure determined by ultrasonic biomicroscopy in eyes with shallow anterior chambers. Ophthalmology, 112:407-412, 2005.
PubMed
3) Mishima K, et al.:Iridotrabecular contact observed using anterior segment three-dimensional OCT in eyes with a shallow peripheral anterior chamber. Invest Ophthalmol Vis Sci, 54:4628-4635, 2013.
PubMed
P.75 掲載の参考文献
1) Kanamori A, et al.:Cluster analyses of grid-pattern display in macular parameters using optical coherence tomography for glaucoma diagnosis. Invest Ophthalmol Vis Sci, 54:6401-6408, 2013.
PubMed
2) Nakatani Y, et al.:Evaluation of macular thickness and peripapillary retinal nerve fiber layer thickness for detection of early glaucoma using spectral domain optical coherence tomography. J Glaucoma, 20:252-259, 2011.
PubMed
3) Mwanza JC, et al.:Glaucoma diagnostic accuracy of ganglion cell-inner plexiform layer thickness:comparison with nerve fiber layer and optic nerve head. Ophthalmology, 119:1151-1158, 2012.
PubMed
4) Takayama K, et al.:A novel method to detect local ganglion cell loss in early glaucoma using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci, 53:6904-6913, 2012.
PubMed
5) Akashi A, et al.:Comparative assessment for the ability of Cirrus, RTVue, and 3D-OCT to diagnose glaucoma. Invest Ophthalmol Vis Sci, 54:4478-4484, 2013.
PubMed
6) Lisboa R, et al.:Comparison of different spectral domain OCT scanning protocols for diagnosing preperimetric glaucoma. Invest Ophthalmol Vis Sci, 54:3417-3425, 2013
PubMed
P.80 掲載の参考文献
1) Swindale NV, et al.:Automated analysis of normal and glaucomatous optic nerve head topography images. Invest Ophthalmol Vis Sci, 41:1730-1742, 2000.
PubMed
2) Saito H, et al.:Sensitivity and specificity of the Heidelberg Retina Tomograph II Version 3.0 in a population-based study:the Tajimi Study. Ophthalmology, 116:1854-1861, 2009
 
3) 八百枝 潔, ほか:日本人健常人データベースを用いたハイデルベルグレチナトモグラフの緑内障診断力. 臨眼, 61(臨増):30, 2007.
 
4) 武田 久, ほか:緑内障検診眼でのハイデルベルグレチナトモグラフによる緑内障診断力の比較検討. 日眼会誌, 112(臨増):243, 2008.
 
5) Rao HL, et al.:Comparison of the diagnostic capability of the Heidelberg Retina Tomographs 2 and 3 for glaucoma in the Indian population. Ophthalmology, 117:275-281, 2010.
PubMed
P.85 掲載の参考文献
1) Medeiros FA, et al.:Comparison of the GDx VCC scanning laser polarimeter, HRT II confocal scanning laser ophthalmoscope, and stratus OCT optical coherence tomograph for the detection of glaucoma. Arch Ophthalmol, 122:827-837, 2004.
PubMed
2) Banks MC, et al:Scanning laser polarimetry of edematous and atrophic optic nerve heads. Arch Ophthalmol, 121:484-490, 2003.
PubMed
3) Kupersmith MJ, et al.:Scanning laser polarimetry reveals status of RNFL integrity in eyes with optic nerve head swelling by OCT. Invest Ophthalmol Vis Sci, 53:1962-1970, 2012.
PubMed
4) Gotzinger E, et al.:Analysis of the origin of atypical scanning laser polarimetry patterns by polarization-sensitive optical coherence tomography. Invest Ophthalmol Vis Sci, 49:5366-5372, 2008.
PubMed
5) Toth M, Hollo G:Enhanced corneal compensation for scanning laser polarimetry on eyes with atypical polarisation pattern. Br J Ophthalmol, 89:1139-1142, 2005.
PubMed
6) Mai TA, et al:Diagnostic accuracy of scanning laser polarimetry with enhanced versus variable corneal compensation. Ophthalmology, 114:1988-1993, 2007.
PubMed

(II) 点眼治療

P.92 掲載の参考文献
1) 日本緑内障学会緑内障診療ガイドライン作成委員会:緑内障診療ガイドライン第3版. 日本眼科学会雑誌, 116:5-46, 2012.
 
2) 岩田和雄:低眼圧緑内障および原発開放隅角緑内障の病態と視神経障害機構. 日本眼科学会雑誌, 96:1501-1531, 1992.
 
3) Van der Valk R, et al.:Intraocular pressure-lowing effects of all commonly used glaucoma drug:a meta-analysis of randomized clinical trials. Ophthalmology, 112:1177-1185, 2005.
 
P.95 掲載の参考文献
1) Baltmr A, et al.:Neuroprotection in glaucoma-Is there a future role? Exp Eye Res, 91:554-566, 2010.
 
2) Nitta E, et al.:Aldosterone:a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma. Cell Death Dis, 4:e711, 2013.
PubMed
3) Wheeler LA, et al.:Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma. Surv Ophthalmol, 45:290-294, 2001.
 
4) Krupin T, et al.:A randomized trial of brimonidine versus timolol in preserving visual function:results from the Low-Pressure Glaucoma Treatment Study. Am J Ophthalmol, 151:671-681, 2011.
PubMed
P.99 掲載の参考文献
1) Chen PP:Blindness in patients with treated open-angle glaucoma. Ophthalmology, 110:726-733, 2003.
PubMed
2) Prochaska JO, DiClemente CC:Stage and process of selfchange of smoking:toward an integrative model of change. J Consult Clin Psychol, 51:390-395, 1983.
 
3) 上島国利, ほか:薬物アドヒアランス. 精神神経学雑誌, 107:696-703, 2005.
 
4) Osterberg L, Blaschke T:Adherence to medication. N Engl J Med, 353:487-497, 2005.
PubMed
P.102 掲載の参考文献
1) 川瀬和秀, 植木啓文:抗精神病薬投与中の慢性閉塞隅角緑内障. 日本医事新報, 4017:113-114, 2001.
 
2) South East Asia Glaucoma Interest Group:Systemic medications that may induce angle closure. Asia Pacific Glaucoma Guidelines, Appendix 3:76, 2008.
 
3) 日本皮膚科学会アトピー性皮膚炎診療ガイドライン作成委員会:アトピー性皮膚炎診療ガイドライン. 日皮会誌, 119:1515-1534, 2009.
 
P.105 掲載の参考文献
1) Kooner KS, Zimmermand TJ.:Antiglaucoma therapy during pregnancy-part I. Ann Ophthalmol, 20:166-169, 1988.
 
2) Akar Y, et al.:Effect of pregnancy on intraobserver and interobserver agreement in intraocular pressure measurements. Ophthalmologica, 219:36-42, 2005.
 
3) Qureshi IA, et al.:Intraocular pressure trends in pregnancy and in the third trimester hypertensive patients. Acta Obstet Gynecol Scand, 75:816-819, 1996.
PubMed
4) Avasthi P, et al.:Effect of pregnancy and labor on intraocular pressure. Int Surg, 61:82-84, 1976.
PubMed
5) Brauner SC, et al.:The course of glaucoma during pregnancy. A retrospective case series. Arch Ophthalmol, 124:1089-1094, 2006.
PubMed
6) South East Asia Glaucoma Interest Group:Treatment in pregnancy and lactation. Asia Pacific Glaucoma Guidelines, Appendix 2:74-75, 2008.
 
7) 国松志保:妊婦, 授乳婦への緑内障治療方針. 眼科診療クオリファイ, 11. 緑内障薬物治療ガイド, 249-254, 中山書店, 2012.
 
8) 斉藤代志明:乳幼児発達緑内障の薬物治療の注意点. 眼科診療クオリファイ11. 緑内障薬物治療ガイド, 244-248, 2012.
 
9) Black AC, et al.:Latanoprost in pediatric glaucoma-pediatric exposure over a decade. J AAPOS, 13:558-562, 2009.
 
10) Coppens G, et al.:The safety and efficacy of glaucoma medications in the pediatric population. J Pediatr Ophthalmol Strabismus, 46:12-18, 2009.
PubMed

(III) 術式選択と術後管理

P.125 掲載の参考文献
1) 黒田真一郎:目標眼圧の有用性と限界 長期経過からみた考察 トラベクロトミー症例からみた目標眼圧. Frontiers in Glaucoma, 7:192-193, 2006.
 
2) 稲谷 大, 谷原 秀信:トラベクロトミーや隅角癒着解離術後のピロカルピンはいつまで続ければよいか. 眼科診療プラクティス, 70, 31, 文光堂, 2001.
 
P.129 掲載の参考文献
1) 竹下弘伸, ほか:落屑緑内障に対する再度の線維柱帯切開術の成績. あたらしい眼科, 29:1276-1280, 2012.
Medical*Online
P.139 掲載の参考文献
1) Good TJ, Kahook MY:Assessment of bleb morphologic feature and postoperative outcome after Ex-PRESS drainage device implantation versus trabeculectomy. Am J Ophthalmol, 151(3):507-513, 2011.
PubMed
2) Sugiyama T, et al.:The first report on intermediate-term outcome of Ex-PRESS glaucoma filtration device implanted under scleral flap in Japanese patients. Clin Ophthalmol, 5:1063-1066, 2011.
PubMed
3) Beltran-Agullo L, et al.:Comparison of Visual Recovery Following Ex-PRESS Versus Trabeculectomy:Results of a Prospective Randomized Controlled Trial. J Glaucoma, 2013 Jun 25. [Epub ahead of print]
 
4) Maris PJ G, et al.:Comparison of trabeculectomy with Ex-PRESS miniature glaucoma device implanted under scleral flap. J Glaucoma, 16(1):14-19, 2007.
PubMed
5) Wang W, et al.:Ex-PRESS implantation versus trabeculectomy in uncontrolled glaucoma:a meta-analysis. PLoS One, 8(5):e63591, 2013.
PubMed
P.143 掲載の参考文献
1) Gedde SJ, et al.:Tube versus Trabeculectomy Study Group:Treatment outcomes in the Tube Versus Trabeculectomy(TVT) study after five years of follow-up. Am J Ophthalmol, 153(5):789-803, 2012.
 
P.149 掲載の参考文献
1) Gedde SJ, et al.:Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up. Am J Ophthalmol, 143(1):23-31, 2012.
 
2) Witmer MT, et al.:Long-term intraocular pressure control and corneal graft survival in eyes with a pars plana Baerveldt implant and corneal transplant. J Glaucoma, 19(2):124-131, 2010.
 
P.161 掲載の参考文献
1) Kramer TR, Noecker RJ:Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology, 108:773-779, 2001.
PubMed
2) Damji KF, et al.:Selective laser trabeculoplasty versus argon laser trabeculoplasty:results from a 1-year randomized clinical trial. Br J Ophthalmol, 90:1490-1494, 2006.
PubMed
3) Juzych MS, et al.:Comparison of long-term outcomes of selective laser trabeculoplasty versus argaon laser trabeculoplasty in open-angle glaucoma. Ophthalmology, 111:1853-1859, 2004.
PubMed
P.165 掲載の参考文献
1) Huang G, Lin SC:When should we give up filtration surgery:indications, techniques and results of cyclodestruction. Dev Ophthalmol, 50:173-183, 2012.
 
2) Ishida K:Update on results and complications of cyclophotocoagulation. Curr Opin Ophthalmol, 24(2):102-110, 2013.
PubMed
3) Lai JS, et al.:Diode laser transscleral cyclophotocoagulation as primary surgical treatment for medically uncontrolled chronic angle closure glaucoma:long-term clinical outcomes. J Glaucoma, 14:114-119, 2005.
PubMed
4) Tam DY:Treating Glaucoma:In Defense of ECP;Toronto;Review of Ophthalmology, March 15, 2013.
 
5) Gayton JL, et al.:Combined cataract and glaucoma surgery:trabeculectomy versus endoscopic laser cyclophotoablation. J Cat Ref Surgery, 25:1214-1219, 1999.
 
6) Lima FE, et al.:A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. J Glaucoma, 13:233-237, 2004.
PubMed
7) Yildirim N, et al.:A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma:a long-term follow-up. J Glaucoma, 18:192-196, doi:10.1097/IJG.0b013e31817d235c, 2009.
 

(IV) 病型別診断と治療

P.173 掲載の参考文献
1) Iwase A, et al.:Tajimi Study Group, Japan Glaucoma Society:The prevalence of primary open-angle glaucoma in Japanese:the Tajimi Study. Ophthalmology, 111(9):1641-1648, 2004.
 
2) Kass MA, et al.:The Ocular Hypertension Treatment Study:a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol, 120(6):701-713, 2002.
 
3) Marcus MW, et al.:Myopia as a risk factor for open-angle glaucoma:a systematic review and meta-analysis. Ophthalmology, 118(10):1989-1994, 2011.
PubMed
4) Morgan WH, et al.:The role of cerebrospinal fluid pressure in glaucoma pathophysiology:the dark side of the optic disc. J Glaucoma, 17(5):408-413, 2008.
PubMed
5) Heijl A, et al.;Early Manifest Glaucoma Trial Group:Reduction of intraocular pressure and glaucoma progression:results from the Early Manifest Glaucoma Trial. Arch Ophthalmol, 120(10):1268-1279, 2002.
 
6) The AGIS Investigators:The Advanced Glaucoma Intervention Study (AGIS):7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol, 130(4):429-440, 2000.
PubMed
7) Ishida K, et al.:Disk hemorrhage is a significantly negative prognostic factor in normal-tension glaucoma. Am J Ophthalmol, 129(6):707-714, 2000.
PubMed
P.179 掲載の参考文献
1) 日本緑内障学会緑内障診療ガイドライン作成委員会:緑内障診療ガイドライン 第3版.
 
P.183 掲載の参考文献
1) Collaborative Normal-Tension Glaucoma Study Group:Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol, 126:487-497, 1998.
 
2) Krupin T, et al.:A randomized trial of brimonidine versus timolol in preserving visual function:results from the Low-Pressure Glaucoma Treatment Study. Am J Ophthalmol, 151:671-681, 2011.
PubMed
3) Maier PC, et al.:Treatment of ocular hypertension and open angle glaucoma:meta-analysis of randomized controlled trials. BMJ, 331:124, 2005.
 
4) Caprioli J, et al.:Comparison of visual field defects in the low-tension glaucomas with those in the high-tension glaucomas. Am J Ophthalmol, 97:730-737, 1984.
PubMed
5) Araie M, et al.:Visual field defects in normal-tension and high-tension glaucoma. Ophthalmology, 100:1808-1814, 1993.
PubMed
6) Collaborative Normal-Tension Glaucoma Study Group:Natural history of normal-tension glaucoma. Ophthalmology, 108:247-253, 2001.
 
7) Sugiyama K, et al.:The association of optic disc hemorrhage with retinal nerve fiber layer defect and peripapillary atrophy in normal-tension glaucoma. Ophthalmology, 104:1926-1933, 1997.
PubMed
8) Ishida K, et al.:Disk hemorrhage is a significantly negative prognostic factor in normal-tension glaucoma. Am J Ophthalmol, 129:707-714, 2000.
PubMed
9) Drance S, et al.:Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol, 131:699-708, 2001.
PubMed
10) Kono Y, et al.:Characteristics of visual field progression in patients with normal-tension glaucoma with optic disk hemorrhages. Am J Ophthalmol, 135:499-503, 2003.
PubMed
11) Tomita G.:The optic nerve head in normal tension glaucoma. Curr Opin Ophthalmol, 11:116-120, 2000.
PubMed
12) Park HY, et al.:Enhanced depth imaging detects lamina cribrosa thickness differences in normal tension glaucoma and primary open-angle glaucoma. Ophthalmology, 119:10-20, 2012.
PubMed
13) Park SC, et al.:Factors associated with focal lamina cribrosa defects in glaucoma. Invest Ophthalmol Vis Sci, 54:8401-8407, 2013.
PubMed
14) Berdahl Jp, et al.:Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology, 115:763-768, 2008.
PubMed
15) Fleischman D, et al.:Cerebrospinal fluid pressure decreases with older age. Plos One, 7;e52664, 2012.
PubMed
16) Wostyn P, et al.:Senescent changes in cerebrospinal fluid circulatory physiology and their role in the pathogenesis of normal-tension glaucoma. Am J Ophthalmol, 156:5-14, 2013.
PubMed
P.185 掲載の参考文献
1) Yanagi M, et al.:Vascular risk factors in glaucoma:a review. Clin Experiment Ophthalmol, 39:252-258, 2011.
PubMed
2) 澤口昭一:緑内障の本態 緑内障性視神経障害 機械的圧迫説の立場から. 臨床眼科, 50:11-15, 1996.
 
3) Amerasinghe N, et al.:Evidence of retinal vascular narrowing in glaucomatous eyes in an Asian population. Invest Ophthalmol Vis Sci, 49:5397-5402, 2008.
 
4) Mitchell P, et al.:Retinal microvascular signs and risk of stroke and stroke mortality. Neurology, 65:1005-1009, 2005.
PubMed
5) Kawasaki R, et al.:Retinal vessel caliber is associated with the 10-year incidence of glaucoma:the Blue Mountains Eye Study. Ophthalmology, 120:84-90, 2012.
PubMed
6) Drance S, et al.:Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol, 131:699-708, 2001.
PubMed
7) Choi J, et al.:Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma. Invest Ophthalmol Vis Sci, 48:104-111, 2007.
PubMed
8) Tokunaga T, et al.:Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normaltension glaucoma. Jpn J Ophthalmol, 48:380-385, 2004.
PubMed
P.191 掲載の参考文献
1) Kim TW, et al.:Optic disc change with incipient myopia of childhood. Ophthalmology, 119:21-26, 2012.
PubMed
2) Jonas JB, et al.:Lamina cribrosa thickness and spatial relationships between intraocular space and cerebrospinal fluid space in highly myopic eyes. Invest Ophthalmol Vis Sci, 45:2660-2665, 2004.
PubMed
3) Jonas JB, et al.:Parapapillary atrophy:histological gamma zone and delta zone. PloS One, 7:e47237, 2012.
PubMed
4) Kimura Y, et al.:Retinal nerve fiber layer defects in highly myopic eyes with early glaucoma. Invest Ophthalmol Vis Sci, 53:6472-6478, 2012.
PubMed
P.195 掲載の参考文献
1) McGwin G, Jr, et al.:Visual field defects and the risk of motor vehicle collisions among patients with glaucoma. Invest Ophthalmol Vis Sci, 46:4437-4441, 2005.
PubMed
2) Tanabe S, et al.:The association between primary openangle glaucoma and motor vehicle collisions. Invest Ophthalmol Vis Sci, 52:4177-4181, 2011.
PubMed
3) Crabb DP, at al.:How does glaucoma look?:patient perception of visual field loss. Ophthalmology, 120:1120-1126, 2013.
 
4) http://www.eri.harvard.edu/faculty/peli/papers/viv9.pdf
 
5) Charman WN:Vision and driving-a literature review and commentary. Ophthalmic Physiol Opt, 17:371-391, 1997.
PubMed
6) Freeman EE, et al.:Driving status and risk of entry into longterm care in older adults. Am J Public Health, 96:1254-1259, 2006.
PubMed
7) Ragland DR, et al.:Driving cessation and increased depressive symptoms. J Gerontol A Biol Sci Med Sci, 60:399-403, 2006.
 
P.201 掲載の参考文献
1) Iwase A, et al.:The prevalence of primary open-angle glaucoma in Japanese;the Tajimi Study. Ophthalmology, 111:1641-1648, 2004. (多治見スタディの対象の眼圧分布と緑内障病型(高眼圧症を含む)の有病率)
 
2) Kass MA, et al.:The Ocular Hypertension Treatment Study:a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary openangle glaucoma. Arch Ophthalmol, 120:701-713, discussion 829-730, 2004.(OHTSにおける原発開放隅角緑内障の発症率の検討)
 
3) Gordon MO, et al.:The Ocular Hypertension Treatment Study:baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol, 120:714-720, 2002.(OHTSにおける原発開放隅角緑内障発症の予測因子の検討)
 
4) The European Glaucoma Prevention Study (EGPS) Group:Results of the European Glaucoma Prevention Study. Ophthalmology, 112:366-375, 2005.(EGPSの緑内障発症率および予測因子の検討結果)
 
P.209 掲載の参考文献
1) Yamamoto T, et al.:The Tajimi Study report 2:The prevalenceof primary angle-closure glaucoma, secondary glaucoma in a Japanese population. Ophthalmology, 112:1661-1669, 2005.
 
2) Sawaguchi S, et al.:Prevalence of primary angle closure and primary angle-closure glaucoma in a southwestern rural population of Japan:the kumejima study. Ophthalmology, 119:1134-1142, 2012.
 
3) Foster P, et al.:Angle Closure and Angle Closure Glaucoma:Reports and Consensus Statements of the 3rd Global Aigs Consensus Meeting on Angle Closure Galucoma. ed:Weinreb RN, Friedman DS. Kugler Publications, 2006.
 
4) 日本緑内障学会:緑内障診療ガイドライン(第3版). 日眼会誌, 116:3-46, 2012.
 
5) Ishikawa H, et al.:Quantitative assessment of the anterior segment using ultrasound biomicroscopy.Curr Opin Ophthalmol, 11:133-139, 2000.
PubMed
P.215 掲載の参考文献
1) 日本緑内障学会:緑内障診療ガイドライン(第3版). 日眼会誌, 116:3-46, 2012.
 
2) Lam DS, et al.:Current approaches to the management of acute primary angle closure. Curr Opin Ophthalmol, 18:146-151, 2007.
 
3) Jacobi PC, et al.:Primary phacoemulsification and intraocular lens implantation for acute angle-closure glaucoma.Ophthalmology, 109:1597-1603, 2002.
PubMed
4) Ang LP, et al.:Argon laser iridotomy-induced bullous keratopathy a growing problem in Japan. Br J Ophthalmol, 91:1613-1615, 2007.
PubMed
5) Shimazaki J, et al.:National survey on bullous keratopathy in Japan.Cornea, 26:274-278, 2007.
PubMed
P.233 掲載の参考文献
1) Ohguro N, et al.:The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol, 56:432-435, 2012.
PubMed
2) Neri P, et al.:Incidence of glaucoma in patients with uveitis. J Glaucoma, 13:461-465, 2004.
PubMed
3) Sugita S, et al.:Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis. Br J Ophthalmol, 92:928-932, 2008.
PubMed
4) Sugita S, et al.:Detection of Candida and Aspergillus species DNA using broad-range real-time PCR for fungal endophthalmitis. Graefes Arch Clin Exp Ophthalmol, 250:391-398, 2012.
PubMed
5) Miyanaga M, et al.:A significant association of viral loads with corneal endothelial cell damage in cytomegalovirus anterior uvitis. Br J Ophthalmol, 94:336-340, 2010.
 
6) Panek WC, et al.:Glaucoma in patients with uveitis. Br J Ophthalmol, 74:223-227, 1990.
PubMed
7) Yamada Y, et al.:Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment. Br J Ophthalmol, 95:205-208, 2011.
PubMed
P.241 掲載の参考文献
1) Schlotzer-Schrehardt U, Naumann GO:Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol, 141:921-937, 2006.
PubMed
2) Ritch R, Schlotzer-Schrehardt U:Exfoliation syndrome. Surv Ophthalmol, 45:265-315, 2001.
PubMed
3) Thorleifsson G, et al.:Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science, 317:1397-1400, 2007.
PubMed
4) Tanito M, et al.:LOXL1 variants in elderly Japanese patients with exfoliation syndrome/glaucoma, primary open-angle glaucoma, normal tension glaucoma, and cataract. Mol Vis, 1898-1905, 2008.
PubMed
5) Hyman L, et al.:Natural history of intraocular pressure in the early manifest glaucoma trial:A 6-year follow-up. Arch Ophthalmol, 601-607, 2010.
 
6) Leske MC, et al.:Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology, 114:1965-1972, 2007.
PubMed
7) Ekstrom C:Risk factors for incident open-angle glaucoma:a population-based 20-year follow-up study. Acta Ophthalmol, 90:316-321, 2012.
PubMed
P.247 掲載の参考文献
1) 丸尾敏夫, ほか監修:眼科学 第2版, 文光堂, 2011.
 
2) 眞鍋禮三, ほか監修:角膜クリニック 第2版, 医学書院, 2003.
 
P.251 掲載の参考文献
1) 田原昭彦, ほか:内服によるステロイド緑内障 隅角組織の形態学的および組織学的検索. あたらしい眼科, 10:1181-1187, 1993.
 
2) Tripathi RC, et al.:Corticosteroids and glaucoma risk. Drugs Aging, 15:439-450, 1999.
PubMed
3) Armaly MF:Effect of corticosteroids on intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eye. Arch Ophthalmol, 70:482-491, 1963.
PubMed
4) Armaly MF:Effect of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol, 70:492-499, 1963.
PubMed
5) Becker B, Mills DW:Corticosteroids and intraocular pressure. Arch Ophthalmol, 70:500-507, 1963.
PubMed
6) Garbe E, et al.:Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet, 350:979-982, 1997.
 
7) Inatani M, et al.:Intraocular pressure elevation after injection of triamcinolone acetonide:a multicenter retrospective case-control study. Am J Ophthalmol, 145:676-681, 2008.
PubMed
8) Ohji M, et al.:Marked intraocular pressure response to instillation of corticosteroids in children. Am J Ophthalmol, 112:450-454, 1991.
PubMed
9) Roth DB, et al.:Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection. Ophthalmology, 116:455-460, 2009.
PubMed
10) Iwao K, et al.:Japanese Steroid-Induced Glaucoma Multicenter Study Group:Success rates of trabeculotomy for steroid-induced glaucoma:a comparative, multicenter, retrospective cohort study. Am J Ophthalmol, 151:1047-1056, 2011.
PubMed
P.255 掲載の参考文献
1) Brown GC, et al.:Neovascular glaucoma. Etiologic considerations. Ophthalmology, 91:315-320, 1984.
PubMed
2) Aiello LP, et al.:Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med, 331:1480-1487, 1994.
PubMed
3) Tripanti RC, et al.:Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology, 105:232-237, 1998.
 
4) Wakabayashi T, et al.:Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal disease in 41 consecutive cases. Ophthalmology, 115:1571-1580, 2008.
PubMed
5) Saito Y, et al.:Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma. Acta Ophthalmol, 88:96-102, 2010.
PubMed
6) Takihara Y, et al.:Combined intravitreal bevacizumab and trabeculectomy with mitimycin C versus trabeculectomy with mitimycin C alone for neovascular glaucoma. J Glaucoma, 20:196-201, 2011.
 
7) Shen CC, et al.:Trabeculectomy versus Ahmed glaucoma valve implantation in neovascular glaucoma. Clin Ophthalmol, 5:281-286, 2011.
PubMed
8) Schwartz A:Chronic open-angle glaucoma secondary to rhegmatogenous retinal detachment. Am J Ophthalmol, 75:205-211, 1973.
PubMed
9) Matsuo N, et al.:Photoreceptor outer segments in the aqueous humor in rhegmatogenous retinal detachment. Am J Ophthalmol, 101:673-679, 1986.
PubMed
10) 河西葉子, ほか:アトピー性皮膚炎に伴った網膜剥離の2例-前房内に視細胞外節を認めた症例-. 眼科臨床医報, 86(9):2144-2148, 1992.
 
P.259 掲載の参考文献
1) Shaffer RN, Hoskins HD:Ciliary block(malignant)glaucoma. Ophthalmology, 85:215-221, 1978.
PubMed
2) Lowe RF, Ritch R:Angle-closure glaucoma. The Glaucomas 2nd ed. St Louis, CV Mosby:839-853, 1989.
 
3) 上田 潤, ほか:悪性緑内障の発症とplateau iris configuration. 日本眼科学会雑誌, 101:723-729, 1997.
 
4) Bynes GA, et al.:Vitrectomy for ciliary block(malignant)glaucoma. Ophthalmology, 102:1308-1311, 1995.
 
5) 大喜多隆秀, ほか:特発性uveal effusion syndromeに対する硝子体手術の有効性. 日本眼科学会雑誌, 112:472-475, 2008.
Medical*Online
P.265 掲載の参考文献
1) Chi TS, Netland PA:Angle-recession glaucoma. Int Ophthalmol Clin, 35:117-126, 1995.
PubMed
2) Campagna JA:Traumatic hyphema:current strategies. Focal Points:Clinical Modules for Ophthalmologists. San Francisco:American Academy of Ophthalmology, module 10, 2007.
 
P.269 掲載の参考文献
1) 日本緑内障学会:緑内障診療ガイドライン 第3版:p21, 2012.
 
2) 山本 節, ほか:全身麻酔下における小児眼圧の検討. 臨床眼科, 35:842-846, 1981.
 
3) Stamper RL, et al.:Developmental and childhood glaucoma. In Becker-Shaffer's Diagnosis and Therapy of the Glaucomas 8th ed, 294-329, Mosby Elsevier, 2009.
 
4) Enyedi LB, et al.:Latanoprost for the treatment of pediatric glaucoma. Surv Ophthalmol, 47:129-132, 2002.
 
5) Portellos M, et al.:Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma. J AAPOS, 2:43-47, 1998.
PubMed
6) Becker ML, et al.:Brimonidine tartrate poisoning in children:frequency, trends, and use of naloxone as an antidote. Pediatrics, 123:305-311, 2009.
 

書評

最近チェックした商品履歴

Loading...